Literature DB >> 23557269

Importance of reverse signaling of the TNF superfamily in immune regulation.

Kata Juhász1, Krisztina Buzás, Ernő Duda.   

Abstract

TNF-related ligands (with the exception of lymphotoxin-α) are synthesized as type II transmembrane proteins, though many of them also have soluble forms. An increasing number of publications report that these 'ligands' behave as receptors, activating intracellular signaling pathways when interacting with cognate 'receptors' or agonistic antibodies. Most members of the TNF family and their receptors influence survival, proliferation, differentiation or activation of immune cells. The elicited 'reverse signals' also have significant importance. They proved to be involved in the activation of APCs, T and B cells, differentiation of osteoclasts and apoptosis of activated macrophages. They influence the balance between destructive immune response and tolerance. Several examples show that therapeutic manipulation of the reverse signal can help to treat malignancies as well as autoimmune disorders.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23557269     DOI: 10.1586/eci.13.14

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  21 in total

Review 1.  The Tumor Necrosis Factor Family: Family Conventions and Private Idiosyncrasies.

Authors:  David Wallach
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-10-01       Impact factor: 10.005

2.  Preferential TNFα signaling via TNFR2 regulates epithelial injury and duct obstruction in experimental biliary atresia.

Authors:  Pranavkumar Shivakumar; Tatsuki Mizuochi; Reena Mourya; Sridevi Gutta; Li Yang; Zhenhua Luo; Jorge A Bezerra
Journal:  JCI Insight       Date:  2017-03-09

Review 3.  TNF activity and T cells.

Authors:  Amit K Mehta; Donald T Gracias; Michael Croft
Journal:  Cytokine       Date:  2016-08-13       Impact factor: 3.861

4.  Poxvirus-encoded TNF receptor homolog dampens inflammation and protects from uncontrolled lung pathology during respiratory infection.

Authors:  Zahrah Al Rumaih; Ma Junaliah Tuazon Kels; Esther Ng; Pratikshya Pandey; Sergio M Pontejo; Alí Alejo; Antonio Alcamí; Geeta Chaudhri; Gunasegaran Karupiah
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-12       Impact factor: 11.205

5.  Recombinant CD137-Fc, its synthesis, and applications for improving the immune system functions, such as tumor immunotherapy and to reduce the inflammation due to the novel coronavirus.

Authors:  Maryam Ajami; Mahboobeh Nazari; Habibollah Mahmoodzadeh; Seyed Mohammad Moazzeni
Journal:  J Cell Biochem       Date:  2021-05-16       Impact factor: 4.429

6.  Effect of glutamine enriched nutrition support on surgical patients with gastrointestinal tumor: a meta-analysis of randomized controlled trials.

Authors:  Kai Kang; Xiao-Liang Shu; Yong-Sheng Zhang; Xian-Li Liu; Jian Zhao
Journal:  Chin Med J (Engl)       Date:  2015-01-20       Impact factor: 2.628

Review 7.  Forward and Reverse Signaling Mediated by Transmembrane Tumor Necrosis Factor-Alpha and TNF Receptor 2: Potential Roles in an Immunosuppressive Tumor Microenvironment.

Authors:  Yang Qu; Gang Zhao; Hui Li
Journal:  Front Immunol       Date:  2017-11-28       Impact factor: 7.561

8.  The Chemokine Receptor CXCR6 Evokes Reverse Signaling via the Transmembrane Chemokine CXCL16.

Authors:  Vivian Adamski; Rolf Mentlein; Ralph Lucius; Michael Synowitz; Janka Held-Feindt; Kirsten Hattermann
Journal:  Int J Mol Sci       Date:  2017-07-08       Impact factor: 5.923

9.  The Expression of BTLA Was Increased and the Expression of HVEM and LIGHT Were Decreased in the T Cells of Patients with Rheumatoid Arthritis [corrected].

Authors:  Bin Yang; Zhuochun Huang; Weihua Feng; Wei Wei; Junlong Zhang; Yun Liao; Linhui Li; Xinle Liu; Zhiqiang Wu; Bei Cai; Yangjuan Bai; Lanlan Wang
Journal:  PLoS One       Date:  2016-05-16       Impact factor: 3.240

10.  Anti-TNF certolizumab pegol induces antioxidant response in human monocytes via reverse signaling.

Authors:  Jean Frédéric Boyer; Michel Baron; Arnaud Constantin; Yannick Degboé; Alain Cantagrel; Jean-Luc Davignon
Journal:  Arthritis Res Ther       Date:  2016-03-01       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.